Colombo, Delia
Frassi, Micol
Pagano Mariano, Giusy
Fusaro, Enrico
Lomater, Claudia
Del Medico, Patrizia
Iannone, Florenzo
Foti, Rosario
Limonta, Massimiliano
Marchesoni, Antonio
Raffeiner, Bernd
Viapiana, Ombretta
Grassi, Walter
Grembiale, Rosa Daniela
Guggino, Giuliana
Mazzone, Antonino
Tirri, Enrico
Perricone, Roberto
Sarzi Puttini, Pier Carlo
De Vita, Salvatore
Conti, Fabrizio
Ori, Alessandra
Simoni, Lucia
Fiocchi, Martina
Orsenigo, Roberto
Zagni, Emanuela
,
Frassi, Micol
Caminiti, Maurizio
Fusaro, Enrico
Lomater, Claudia
Del Medico, Patrizia
Iannone, Florenzo
Foti, Rosario
Limonta, Massimiliano
Marchesoni, Antonio
Raffeiner, Bernd
Viapiana, Ombretta
Grassi, Walter
Grembiale, Rosa Daniela
Guggino, Giuliana
Mazzone, Antonino
Tirri, Enrico
Perricone, Roberto
Puttini, Pier Carlo Sarzi
De Vita, Salvatore
Conti, Fabrizio
Funding for this research was provided by:
Novartis Farma S.p.A. Origgio (VA), Italy
Article History
Received: 8 March 2022
Accepted: 10 June 2022
First Online: 12 September 2022
Declarations
:
: The study was conducted in accordance with the amended Declaration of Helsinki. Ethical approvals for this study was obtained from each participating site according to Italian Regulation applicable for prospective observational studies. The patients provided written informed consent before the data collection. The study was approved by the Ethic Committee of the coordinating center (A.O.U. Policlinico-Vittorio Emanuele P.O. San Marco, Catania, Italy) and then by the Ethic Committees of all the participating centers.
: Not applicable.
: DC was a part-time employee of Novartis Farma Italy when the study was conducted. AM has received honoraria and speaker fees from Abbvie, Amgen, Eli-Lilly, Novartis, Pfizer, Janssen, and UCB. AO is employee of MediNeos Observational Research (Modena, Italy), hired by Novartis Farma Italy, responsible for the design and conduction of the CHRONOS study, as well as scientific support, clinical operations, data management, statistical analysis. LS is employee of MediNeos Observational Research (Modena, Italy), hired by Novartis Farma Italy, responsible for the design and conduction of the CHRONOS study, as well as scientific support, clinical operations, data management, statistical analysis.